查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014836

靜脈輸液裝置市場：按裝置類型、技術、應用和最終用戶分類的全球市場預測 – 2026-2032 年

Intravenous System Access Devices Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，靜脈輸液裝置市場價值將達到 51.3 億美元，到 2026 年將成長至 54.7 億美元，到 2032 年將達到 81.2 億美元，複合年成長率為 6.75%。

主要市場統計數據
基準年 2025 51.3億美元
預計年份：2026年 54.7億美元
預測年份 2032 81.2億美元
複合年成長率 (%) 6.75%

背景說明解釋了影響靜脈通路裝置引入和創新的臨床、操作和監管因素。

靜脈通路裝置是現代臨床護理的基石，可在多種治療和診斷中實現持續的血管通路。本分析涵蓋了旨在滿足各種臨床需求的中心靜脈和周邊靜脈通路解決方案，從短期復甦到長期靜脈輸液治療和家庭護理。隨著臨床方案的日益完善，醫療專業人員和採購團隊越來越需要兼具安全性、易用性和與不斷發展的護理路徑相容性的裝置。

分析臨床、技術和供應鏈趨勢的融合，這些趨勢正在重塑整個醫療保健領域的設備設計和部署流程以及籌資策略。

靜脈通路裝置市場正經歷一場變革性的重組，其促進因素包括臨床、技術和經濟等多面向因素的交織。材料和整合安全技術的進步，正從漸進式改進轉向平台層面的提升，優先考慮封閉系統的完整性、連接器標準化以及無針通路，從而降低感染風險。這些技術變革與日益重視以使用者為中心的設計理念相輔相成，降低了手術複雜性，並促進了在非急性照護環境中的應用。

重點評估醫療設備關稅政策的變化如何影響採購決策、製造地和策略供應鏈調整。

貿易政策和關稅趨勢對醫療設備供應鏈的影響日益加劇，籌資策略和成本結構也因此受到更多關注。關稅措施的實施或調整會波及原料採購、零件進口和成品定價，迫使製造商重新評估與供應商和物流系統的合約。對於靜脈輸液裝置而言，由於其通常依賴來自世界各地的聚合物組件、精密製造和滅菌服務，即使關稅負擔略有增加，也會促使製造商重新考慮地理佈局和與供應商的關係。

將設備架構、技術、臨床應用和最終用戶背景連結起來的綜合細分分析揭示了產品的適用性和商業化重點。

一套精細的細分框架清楚地展現了臨床需求、技術和醫療環境之間的交集，從而指導醫療設備的選擇並優先考慮創新。從醫療設備類型來看，市場可分為中心靜脈通路及周邊靜脈通路兩大類。中心靜脈通路包括植入式裝置、非隧道式導管、周邊置入的中央靜脈導管以及隧道式/帶套中央靜脈導管，每種導管都針對不同的治療時間和風險狀況進行了最佳化。周邊通路包括中線導管和周邊靜脈導管。這些導管擴大應用於門診和居家醫療環境中，因為在這些環境中，導管的插入和維護便利性至關重要，它們適用於短期至中期治療。

區域分析比較了美洲、歐洲、中東和非洲以及亞太地區的採購趨勢、監管重點和臨床引入模式。

區域趨勢對整體市場臨床應用、監管流程和商業策略有顯著影響。在美洲，醫療服務提供者面臨著來自私人和公共保險公司的複雜支付體系、高手術量以及完善的門診醫療基礎設施等挑戰，這些因素共同推動了對性能可靠、工作流程精簡且符合嚴格安全標準的醫療器械的需求。在該地區，買家通常優先考慮那些展現出明確臨床價值和營運效率，並擁有完善的報銷管道和成熟分銷網路的產品。

評估市場領導地位和產品長期生存能力的競爭定位、創新路徑和策略夥伴關係。

靜脈通路裝置市場的競爭動態透過差異化的產品系列、策略夥伴關係以及對技術和製造的定向投資而清晰可見。主要企業通常會在其核心產品線之外，推出一系列創新產品，例如提升相容性並降低手術複雜性的整合固定系統、抗菌材料以及連接器標準化舉措。此外，為了滿足臨床醫生的偏好和應對報銷壓力，各公司正在拓展服務範圍，提供培訓、部署協助和遠端監測等支持，旨在降低併發症發生率，並在真實的臨床環境中驗證產品性能。

一套切實可行的策略行動方案，旨在幫助製造商和醫療保健系統將創新、供應鏈韌性、證據產生和商業性實施與實用化相結合。

產業領導企業應推動協作，將產品創新、營運韌性和臨床價值驗證結合。首先，他們必須優先考慮透過整合封閉式系統功能和固定機制來降低感染風險和手術複雜性的設計，同時確保與現有連接器和輸注標準的兼容性。其次，他們應制定兼顧成本效益和供應鏈韌性的生產策略。具體而言，這包括實現組件來源多元化、認證區域生產合作夥伴以及維持儲備庫存，以確保即使在中斷期間也能保證臨床供應的連續性。

對混合方法研究途徑進行透明的解釋，該方法整合了來自臨床醫生的初步發現、二級監管和技術審查以及供應鏈映射。

為確保研究的嚴謹性和實用性，本分析所依據的研究結合了結構化的初步調查、全面的二次文獻綜述以及系統級供應鏈映射。初步調查包括對急診和門診環境中的臨床醫生、採購經理、監管專家和醫療設備工程師的訪談，旨在收集有關器械性能、應用障礙和工作流程整合的第一手資料。基於這些訪談，我們對真實臨床實踐中的關鍵產品屬性和應用促進因素進行了定性優先排序。

簡要總結結論，重點強調臨床優先事項、監管準備和供應鏈韌性是靜脈通路裝置。

總而言之，靜脈通路裝置仍然是現代醫療服務的重要組成部分，其發展演變反映了醫療服務向門診治療、感染預防和彈性供應鏈方向轉變的趨勢。目前，臨床實務優先考慮兼具安全性、易用性和在不同醫療環境中適用性的裝置，而製造商則面臨著對實證醫學、法規遵循和營運連續性日益成長的期望。因此，成功的關鍵在於將產品創新與實際臨床工作流程和採購實際情況結合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 靜脈輸液裝置市場：依裝置類型分類

  • 中心靜脈通路
    • 嵌入式裝置
    • 非隧道導管
    • 周邊置入的中央靜脈導管
    • 隧道式袖中央靜脈導管
  • 周邊靜脈通路
    • 中線導管
    • 周邊靜脈導管

第9章：靜脈輸液裝置市場：依技術分類

  • 封閉式系統
  • 整合系統
  • 開放系統

第10章 靜脈輸液裝置市場：依應用領域分類

  • 輸血
  • 診斷測試
  • 藥物管理
  • 靜脈輸液和營養支持

第11章 靜脈輸液裝置市場：依最終用戶分類

  • 門診手術中心
  • 居家醫療及長期照護機構
  • 醫院和診所

第12章 靜脈輸液裝置市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 靜脈輸液裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 靜脈輸液裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國靜脈輸液裝置市場

第16章：中國靜脈輸液裝置市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Access Vascular, Inc.
  • Angiplast Private Limited
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Delta Med SpA
  • Disposafe Health and Life Care Ltd.
  • FAS United Medical Company
  • Fresenius SE & Co. KGaA
  • Hangzhou Fushan Medical Appliances Co., LTD.
  • Harsoria Healthcare Pvt Ltd
  • IV Access Technology, Inc.
  • ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
  • Kimal PLC
  • Medilivescare Manufacturing Private Limited
  • Medivac Surgical Pvt. Ltd.
  • Medtronic PLC
  • Narang Medical Limited
  • Ningbo GreatCare Trading Co., Ltd.
  • Nipro Corporation
  • Poly Medicure Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Vygon SAS
Product Code: MRR-43127F7279F2

The Intravenous System Access Devices Market was valued at USD 5.13 billion in 2025 and is projected to grow to USD 5.47 billion in 2026, with a CAGR of 6.75%, reaching USD 8.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.13 billion
Estimated Year [2026] USD 5.47 billion
Forecast Year [2032] USD 8.12 billion
CAGR (%) 6.75%

A contextual introduction that explains the clinical, operational, and regulatory drivers shaping adoption and innovation in vascular access devices

Intravenous system access devices constitute a foundational element of contemporary clinical care, enabling sustained vascular access for a broad spectrum of therapies and diagnostics. The devices covered in this analysis span central and peripheral vascular access solutions designed to meet diverse clinical requirements, from short-term resuscitation to long-term infusion and home-based therapies. As clinical protocols have grown more sophisticated, practitioners and procurement teams increasingly demand devices that combine safety features, ease of use, and compatibility with evolving care pathways.

This report opens by situating these devices within the broader clinical and operational context. It examines how demographic shifts, rising chronic disease prevalence, expanded outpatient care, and the migration of complex therapies to ambulatory and home settings have altered device utilization patterns. Regulatory scrutiny and infection prevention priorities remain central drivers of product design and procurement choices. Consequently, manufacturers have concentrated on materials science, integrated safety, and workflow-oriented innovations to reduce complications and streamline clinical procedures.

Transitioning from context to strategic priorities, the introduction clarifies the report's scope and analytical framework. It outlines the device categories and technological classifications under review, explains the clinical applications considered, and summarizes the methodological approach used to evaluate suppliers, clinical adoption barriers, and regulatory dynamics that shape product lifecycles.

An analysis of converging clinical, technological, and supply chain trends that are reshaping device design adoption pathways and procurement strategies across care settings

The intravenous access device landscape has entered a period of transformative realignment driven by converging clinical, technological, and economic forces. Advances in materials and integrated safety technologies have moved beyond incremental improvements toward platform-level enhancements that prioritize closed-system integrity, connector standardization, and needleless access to reduce infection risk. These technological shifts coincide with a growing emphasis on user-centered design that lowers procedure complexity and supports adoption across settings beyond the acute hospital.

Meanwhile, clinical practice patterns are evolving. The expansion of outpatient infusion therapies and the acceleration of home healthcare programs have created new demand signals for midline and peripherally inserted devices that balance duration of therapy with insertion safety and ease of maintenance. Regulatory agencies have increased focus on post-market surveillance and device traceability, prompting manufacturers to invest in labeling, unique device identification, and quality systems that facilitate rapid corrective action when needed. In parallel, supply chain resilience has become a strategic priority; stakeholders are diversifying suppliers and reshoring critical manufacturing steps to mitigate disruption risk.

Taken together, these shifts demand that companies align R&D, manufacturing, and commercial models to support cross-setting care, integrate safety and connectivity features, and deliver systems that fit both clinician workflows and patient-centered care pathways.

A focused evaluation of how evolving tariff policies are influencing sourcing decisions manufacturing footprints and strategic supply chain adjustments for medical devices

Trade policy and tariff dynamics affecting medical device supply chains have intensified scrutiny of sourcing strategies and cost structures. When tariff measures are applied or adjusted, they transmit through raw material procurement, component imports, and finished device pricing, prompting manufacturers to reassess vendor contracts and logistics arrangements. For intravenous access devices, which often rely on polymer components, precision manufacturing, and sterilization services sourced globally, any incremental tariff burden increases the incentive to re-evaluate geographic footprints and supplier relationships.

Consequently, stakeholders have undertaken scenario planning to understand cumulative cost exposure, timing of tariff implementation, and mitigation pathways such as localizing production, qualifying alternative suppliers, or redesigning products to reduce dependence on tariff-sensitive inputs. Transitional impacts include renegotiated supplier contracts, phased inventory adjustments, and greater emphasis on supply chain visibility to prevent margin erosion while preserving product availability for clinicians and patients.

Importantly, the operational response to tariff-driven pressure does not occur in isolation. Regulatory compliance, quality oversight, and time-to-market constraints shape the feasibility and pace of supply chain shifts. As a result, many firms prioritize a hybrid approach that combines nearshoring for critical components with diversified global sourcing for commoditized inputs, while employing contractual and operational hedges to maintain continuity and manage financial exposure.

A comprehensive segmentation synthesis linking device architectures technologies clinical applications and end-user contexts to illuminate product fit and commercialization priorities

A nuanced segmentation framework clarifies where clinical need, technology, and care setting intersect to shape device selection and innovation priorities. By device type, markets separate into central intravenous access and peripheral intravenous access categories. Central options encompass implantable devices, non-tunneled catheters, peripherally inserted central catheters, and tunneled and cuffed central catheters, each optimized for differing duration of therapy and risk profiles. Peripheral access includes midline catheters and peripheral intravenous catheters, which address short- to intermediate-duration therapies and are increasingly used in ambulatory and home settings where ease of insertion and maintenance are critical.

From a technology standpoint, devices cluster into closed systems, integrated systems, and open systems. Closed systems emphasize infection prevention through sealed pathways, integrated systems combine multiple functional elements such as securement and access management into unified platforms, and open systems prioritize modularity and interchangeability. These technological distinctions drive procurement choices depending on clinical priorities, interoperability requirements, and staff training considerations.

The application dimension captures how clinical use cases influence device specification, covering blood transfusion, diagnostic testing, drug administration, and fluid and nutritional support. Each application poses different flow, compatibility, and dwell-time demands that inform product selection and procedural protocols. Finally, end-user segmentation distinguishes ambulatory surgical centers, homecare settings and long-term care facilities, and hospitals and clinics, recognizing that device features and packaging must align with the capabilities and workflows of each care environment. Together, these segmentation lenses provide a practical structure for evaluating product fit, development priorities, and commercialization strategies.

A regional analysis that contrasts procurement dynamics regulatory priorities and clinical adoption patterns across the Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics materially influence clinical adoption, regulatory pathways, and commercial strategies across the market. In the Americas, healthcare providers navigate a complex mix of private and public payers, high procedural volumes, and robust outpatient care infrastructure, driving demand for devices that deliver reliable performance, streamlined workflows, and compliance with stringent safety standards. In this region, purchasers often prioritize products that demonstrate clear clinical value and operational efficiencies, supported by strong reimbursement pathways and established distribution networks.

In Europe, the Middle East and Africa, regulators emphasize harmonized safety standards, while health systems vary widely in procurement sophistication and budgetary constraints. Stakeholders in this region balance affordability with compliance, and they increasingly adopt technologies that demonstrate reduced complication rates and lower total cost of care. In addition, private-sector growth and public health investments create opportunities for product differentiation based on quality and post-market support.

Across Asia-Pacific, rapid modernization of healthcare infrastructure, expanding access to outpatient and homecare services, and domestic manufacturing ambitions shape a dynamic competitive landscape. Manufacturers pursuing this region prioritize scalable production models, regulatory engagement, and adaptations for local clinical practices and procurement mechanisms. Collectively, these regional patterns require manufacturers to customize go-to-market approaches, regulatory strategies, and supply chain footprints to align with each area's clinical priorities and operational realities.

An assessment of competitive positioning innovation pathways and strategic partnerships that determine market leadership and long-term product viability

Competitive dynamics in the intravenous access device market manifest through differentiated portfolios, strategic partnerships, and targeted investments in technology and manufacturing. Leading organizations typically balance core product lines with adjacent innovations such as integrated securement systems, antimicrobial materials, and connector standardization initiatives that facilitate compatibility and reduce procedural complexity. In response to clinician preferences and reimbursement pressures, companies have also extended services that support training, adoption, and remote monitoring to reduce complication rates and demonstrate real-world performance.

Mergers and strategic alliances remain a common pathway for acquiring capability in materials science, sterilization technologies, and closed-system engineering. Concurrently, smaller specialized firms often focus on niche clinical problems or platform innovations that larger manufacturers selectively acquire or license. Transitioning from R&D to scale requires robust quality systems and regulatory acumen, so many companies invest in regional manufacturing and regulatory affairs capabilities to accelerate approvals and local market access.

Supply chain resilience and cost control also shape competitive positioning. Firms that secure diversified, quality-assured supply bases and invest in redundancy enjoy greater flexibility during disruption. Ultimately, market leadership accrues to organizations that combine clinical evidence generation, user-centered design, scalable manufacturing, and commercial models that align with care delivery trends across multiple settings.

A pragmatic set of strategic actions for manufacturers and health systems to align innovation supply chain resilience evidence generation and commercial execution for meaningful adoption

Industry leaders should pursue a coordinated agenda that aligns product innovation with operational resilience and clinical value demonstration. First, prioritize designs that reduce infection risk and procedural complexity by integrating closed-system features and securement mechanisms, while ensuring compatibility with prevailing connector and infusion standards. Second, deploy manufacturing strategies that balance cost efficiency with supply chain resilience; diversify component sourcing, qualify regional production partners, and develop contingency inventories to sustain clinical supply continuity during disruptions.

Third, invest in evidence generation that demonstrates real-world outcomes across hospitals, ambulatory surgical centers, and homecare environments. Transitional adoption often depends on case studies and pilot programs that document reduced complications, shortened procedure times, or lower total care costs. Fourth, strengthen regulatory and post-market surveillance capabilities to accelerate approvals and to respond rapidly to safety signals. Fifth, cultivate commercial models that include clinician training, onboarding support, and service offerings that lower the barrier to adoption in non-hospital settings.

By executing on these priorities in a coordinated manner, companies can improve product-market fit, minimize operational risks associated with trade or supply interruptions, and create durable competitive advantages grounded in clinical impact and operational reliability.

A transparent description of the mixed-methods research approach that integrates primary clinician insights secondary regulatory and technical review and supply chain mapping

The research underpinning this analysis combines structured primary engagements, comprehensive secondary review, and systems-level supply chain mapping to ensure rigor and applicability. Primary research included interviews with clinicians across acute and outpatient settings, procurement leaders, regulatory specialists, and device engineers to capture experiential insights on device performance, adoption barriers, and workflow integration. These discussions informed qualitative prioritization of product attributes and adoption levers that matter in real-world settings.

Secondary research synthesized regulatory guidance, clinical practice recommendations, peer-reviewed literature, and publicly available technical specifications to validate product classifications and to understand safety and performance expectations. Supply chain analysis mapped typical component flows for polymer-based catheters, connectors, and sterilization services, highlighting points of concentration and potential bottlenecks. The methodological approach employed cross-validation between primary and secondary sources, thematic coding of interview responses, and triangulation of technological trends with regulatory trajectories.

To ensure reliability, the research team documented assumptions, reviewed alternative scenarios for policy and trade shifts, and conducted sensitivity checks on operational implications. The result is a defensible, action-oriented synthesis that connects clinical priorities to product attributes and strategic imperatives for manufacturers and health systems.

A concise concluding synthesis that emphasizes clinical priorities regulatory readiness and supply chain resilience as the pillars of strategic success in vascular access devices

In closing, intravenous access devices remain a critical enabler of modern care delivery, and their evolution reflects broader shifts toward outpatient therapies, infection prevention, and resilient supply chains. Clinical demand now prioritizes devices that combine safety, ease of use, and cross-setting applicability, while manufacturers face intensifying expectations for evidence, regulatory compliance, and operational continuity. Consequently, success depends on aligning product innovation with real-world clinical workflows and procurement realities.

Looking ahead, stakeholders who invest in integrated safety features, regional manufacturing flexibility, and robust post-market evidence will be best positioned to meet clinician needs and to navigate regulatory and trade complexities. Moreover, partnerships that accelerate training, streamline adoption, and provide real-world performance data will create tangible differentiation in procurement conversations. As healthcare delivery models continue to decentralize, the firms that translate clinical insight into practical, reliable device systems will capture the most durable opportunities.

Overall, the market presents significant strategic choices; by emphasizing clinical impact, supply chain resilience, and disciplined evidence generation, organizations can deliver meaningful improvements in patient care while building sustainable competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous System Access Devices Market, by Device Type

  • 8.1. Central Intravenous Access
    • 8.1.1. Implantable Devices
    • 8.1.2. Non-tunneled Catheters
    • 8.1.3. Peripherally Inserted Central Catheter
    • 8.1.4. Tunneled & Cuffed Central Catheter
  • 8.2. Peripheral Intravenous Access
    • 8.2.1. Midline Catheter
    • 8.2.2. PIV Catheter

9. Intravenous System Access Devices Market, by Technology

  • 9.1. Closed System
  • 9.2. Integrated System
  • 9.3. Open System

10. Intravenous System Access Devices Market, by Application

  • 10.1. Blood Transfusion
  • 10.2. Diagnostic Testing
  • 10.3. Drug Administration
  • 10.4. Fluid & Nutritional Support

11. Intravenous System Access Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Homecare Settings & Long-term Care Facilities
  • 11.3. Hospitals & Clinics

12. Intravenous System Access Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intravenous System Access Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intravenous System Access Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Intravenous System Access Devices Market

16. China Intravenous System Access Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Access Vascular, Inc.
  • 17.6. Angiplast Private Limited
  • 17.7. Argon Medical Devices, Inc.
  • 17.8. B. Braun SE
  • 17.9. Baxter International Inc.
  • 17.10. Becton, Dickinson and Company
  • 17.11. Delta Med S.p.A.
  • 17.12. Disposafe Health and Life Care Ltd.
  • 17.13. FAS United Medical Company
  • 17.14. Fresenius SE & Co. KGaA
  • 17.15. Hangzhou Fushan Medical Appliances Co., LTD.
  • 17.16. Harsoria Healthcare Pvt Ltd
  • 17.17. I-V Access Technology, Inc.
  • 17.18. ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
  • 17.19. Kimal PLC
  • 17.20. Medilivescare Manufacturing Private Limited
  • 17.21. Medivac Surgical Pvt. Ltd.
  • 17.22. Medtronic PLC
  • 17.23. Narang Medical Limited
  • 17.24. Ningbo GreatCare Trading Co., Ltd.
  • 17.25. Nipro Corporation
  • 17.26. Poly Medicure Limited
  • 17.27. Teleflex Incorporated
  • 17.28. Terumo Corporation
  • 17.29. Vygon SAS

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 130. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 131. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 151. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 152. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 158. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 159. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)